OpenHuman /auth/telegram CSRF allows attacker-controlled session implantation
Collected exploitation and prediction evidence
Risk source coverageCISA KEV is observed exploitation evidence. FIRST EPSS is a dated prediction of exploitation in the next 30 days. Missing scores are unknown. This collector requests predictions only for explicit CVE aliases in the public NuGet archive; Microsoft release views retain their existing prediction scope.
No collected risk observation for these identifiers. This does not establish absence of exploitation or a zero probability.
cve-program · CVE-2026-49410
PublishedOpenHuman is an open-source agent harness available as a desktop application and Rust library. Versions before 0.56.0 allow cross-site request forgery against the unauthenticated GET /auth/telegram loopback callback because telegram_auth_handler consumes an attacker-supplied one-time Telegram login token and passes the returned JWT to credentials::ops::store_session without validating browser fetch metadata or the request origin. An attacker with an OpenHuman account can cause a user with the local core running to visit a malicious page that requests the /auth/telegram endpoint on loopback port 7788, switching the user's active local session to the attacker's backend account and exposing subsequent agent actions, memory writes, and Telegram messages associated with that session to the attacker. This issue is fixed in version 0.56.0.
- Source published
- 16 Oct 2026 21:25:02 UTC
- Source modified
- 19 Oct 2026 21:26:57 UTC
- Observed here
- 23 Oct 2026 15:48:27 UTC
- Source terms
- CVE Program Terms of Use
Original source record · Cite this exact observation · Complete original publisher JSON
This view projects the publisher's source fields for reading; the original JSON retains additional fields and CVE enrichment containers. Attribution: cve-program · CVE Program Terms of Use. Source text is retained; field grouping and change labels are provided by ChangeIntel.
CVSS 3.1 · 8.1 CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N